There is often a conflict between the protocol requirements to efficiently demonstrate endpoints in the clinical development stage, relative to the accurate characterization of real-world target patient populations. This webinar will demonstrate several technology and data-enabled approaches to capturing relevant data in parallel with clinical development to set up Market Access teams for success as early as possible.

Key learning objectives:

  • Introduce methodology to prospectively collect patient-reported data in parallel to phase 3 clinical studies
  • Demonstrate the complementarity of existing forms of RWD/RWE with patient reported data
  • Highlight the benefit of a patient-centric approach and generation of patient journey data to contextualize real world patterns of care


Renee Willmon, MSc
Senior Director, Evidence & Outcomes
Self Care Catalysts, an Alira Health Company

A results-driven leader with a successful track record of innovating in the health sector through research, Renee has a passion for identifying and facilitating synergies between research and business. While data drives today’s digital world, analysis doesn’t always lead to insight. Renee leverages disparate and unexpected sources of data to align research questions with business objectives, and ultimately provides compelling and actionable answers, especially in the areas of Patient Focused Drug Development, Digital Health, and the application of Behavioral Science for Patient Engagement.


Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.